Products in Early Development Stage and Future Projects
Carcinoembryonic Antigen
-
CEA is being sold as a standard to Manufacturers but also as an Antigen
for immunization in research on colorectal Cancer. A C234 Mouse Monoclonal
Antibody to CEA has been raised for Tumour Suppression.
The CEA research will aim at development of anti-CEA as a Homing Device for Products used in Cancer treatment and as a Cancer imaging Tool.
CardioVision II™ (Human)
Research on Human Monoclonal Antibodies against Myosin, using transgenic
Mice.
 |
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||||
 |
|
||||||||